Correlation Between Spruce Biosciences and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Spruce Biosciences and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spruce Biosciences and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spruce Biosciences and Inozyme Pharma, you can compare the effects of market volatilities on Spruce Biosciences and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spruce Biosciences with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spruce Biosciences and Inozyme Pharma.
Diversification Opportunities for Spruce Biosciences and Inozyme Pharma
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Spruce and Inozyme is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Spruce Biosciences and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Spruce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spruce Biosciences are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Spruce Biosciences i.e., Spruce Biosciences and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Spruce Biosciences and Inozyme Pharma
Given the investment horizon of 90 days Spruce Biosciences is expected to generate 0.87 times more return on investment than Inozyme Pharma. However, Spruce Biosciences is 1.15 times less risky than Inozyme Pharma. It trades about -0.08 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.62 per unit of risk. If you would invest 59.00 in Spruce Biosciences on August 29, 2024 and sell it today you would lose (4.00) from holding Spruce Biosciences or give up 6.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spruce Biosciences vs. Inozyme Pharma
Performance |
| Timeline |
| Spruce Biosciences |
| Inozyme Pharma |
Spruce Biosciences and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spruce Biosciences and Inozyme Pharma
The main advantage of trading using opposite Spruce Biosciences and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spruce Biosciences position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Spruce Biosciences vs. Inozyme Pharma | Spruce Biosciences vs. Day One Biopharmaceuticals | Spruce Biosciences vs. Terns Pharmaceuticals | Spruce Biosciences vs. Eledon Pharmaceuticals |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |